NCT02064166View on ClinicalTrials.gov

Treatment of Parkinson Disease and Multiple System Atrophy Using Intranasal Insulin.

PHASE2CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

September 30, 2015

Study Completion Date

September 30, 2015

Conditions
Parkinson DiseaseMultiple System Atrophy
Interventions
DRUG

Intranasal Insulin

"1. treatment arm: Insulin, 40 international units daily, intranasally, for 4 weeks;~2. placebo arm: normal saline, daily, intranasally, for 4 weeks."

Trial Locations (1)

01655

University of Massachusetts Medical School, Worcester

All Listed Sponsors
lead

Peter Novak

OTHER

NCT02064166 - Treatment of Parkinson Disease and Multiple System Atrophy Using Intranasal Insulin. | Biotech Hunter | Biotech Hunter